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ABSTRACT 
The dopaminergic neurons and cholinergic interneurons of the striatum play key roles in motivational and sensorimotor processing by the basal 
ganglia. The striatal dopaminergic transmission in the forebrain is modulated by the excitatory cholinergic projections from the pedunculopontine 
and the laterodorsal tegmental nuclei of the hind brain by activating nicotinic and muscarinic acetylcholine receptors within the substantia nigra 
and ventral tegmental area. Furthermore, acetylcholine-containing interneurons in the striatum also constitute an important neural substrate for 
modulating dopamine activity. The striatal muscarinic acetylcholine receptors, by inhibiting acetylcholine release from cholinergic interneurons and 
thus modifying nicotinic acetylcholine receptor activity, offer variable control of dopamine release probability. In addition, it appears that the 
striatal influence of dopamine and acetylcholine cannot be fully appreciated without an understanding of their reciprocal interactions. Impairments 
or abnormality in these reciprocating interactions is often manifested in the form of various neuropsychiatric disorders and require extensive 
research to establish the optimized drug therapy. Hence the present review will serve as an aid to study the anatomical and physiological aspects of 
dopamine modulation as influenced by acetylcholine in striatum. 
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INTRODUCTION 
Cholinergic cell bodies are located in a loosely contiguous axis running 
from the cranial nerve nuclei of the brain stem to the medullary 
tegmentum and pontomesencephalic tegmentum, continuing rostrally 
through the diencephalon to the telencephalon [1]. There are three 
major cholinergic subsystems above the brain stem that innervate nearly 
every neural area. One cholinergic system arises from neurons mainly in 
the pedunculopontine tegmentum (PPTg) and the laterodorsal pontine 
tegmentum (LDTg), providing widespread innervation to the thalamus 
and midbrain dopaminergic areas and also descending innervation to 
the caudal pons and brain stem. The second major cholinergic system 
arises from various basal forebrain nuclei that make broad projections 
throughout the cortex and hippocampus. The third major cholinergic 
subsystem arises from a collection of cholinergic interneurons located in 
the striatum. 
The cholinergic neurons of the LDTg mainly innervate the Ventral 
tegmental (VTA) neurons, influence their burst firing and the consequent 
release of dopamine in the nucleus accumbens and thereby influence 
goal-directed behaviors. In contrast, the PPTg neurons innervate both 
Substantia nigra pars compacta (SNc) and VTA neurons. The PPTg 
neuronal activity alters dopamine release in the dorsal as well as ventral 
striatum and thereby modifying whole basal ganglia activity through its 
effects on striatal outputs and ultimately behavior. 
Thus the cholinergic and dopaminergic systems have a potent 
reciprocal relationship within the striatum. It has long been 
recognized that Acetylcholine (ACh) and Dopamine (DA) have dense 
overlapping axonal arborizations. ACh regulates striatal DA 
neurotransmission via actions at both Muscarinic acetylcholine 
receptors (mAChRs) and nicotinic acetylcholine receptors (nAChRs) 
in a manner which differ according to the striatal sub region and DA 
neuron activity. In addition, it is widely accepted that the 
mesopontine cholinergic system modulates the midbrain 
dopaminergic system, which is the focus of the present review. 
BASIC ANATOMY OF THE STRIATUM 
The basal ganglia is a group of nuclei of varied origin situated at the 
base of the forebrain and are strongly connected with the cerebral 
cortex, thalamus and other brain areas. The main components of the 
basal ganglia are the striatum (the largest component), pallidum, 
substantia nigra and subthalamic nucleus. The striatum is the major 
input station of the basal ganglia system, extremely rich in 
acetylcholine (ACh) and its associated enzymes Acetyl 
cholinesterase (AChE; the ACh degrading enzyme), Choline acetyl 
transferase (ChAT; the ACh synthesizing enzyme), and cholinergic 
receptors (muscarinic and nicotinic; mAChRs and nAChRs, 
respectively). As the input nucleus of the basal ganglia, the striatum 
receives dopaminergic inputs from the midbrain alongside 
excitatory inputs from both cortex and thalamus. Once the cortical 
information is integrated at the striatal level, it is conveyed to basal 
ganglia output nuclei (e. g., the globus pallidus) via the striatal 
medium spiny neurons (MSNs). The integration is strongly 
modulated by striatal ACh interacting with dopamine (DA) [2]. 
The principal neurons of the striatum are the Medium spiny neurons 
(MSNs), which make up about 90-95% of the total striatal neuronal 
population and form the striatal output. These neurons are 
inhibitory, using γ-aminobutyric acid (GABA) as their primary 
neurotransmitter. These cells have dendrites densely covered with 
dendritic spines; hence their name. The remaining minority of 
neurons is a diverse collection of inter neurons that can be classified 
into three groups. There are the rapidly firing GABAergic 
interneurons that express the calcium binding protein parvalbumin, 
and the somatostatin and nitric oxide expressing interneurons that 
mainly fire in bursts. The much larger cholinergic interneurons 
make up the third group [3]. Each of these three groups of 
interneurons contributes about 1-3% of the striatal neurons. 
Based on connectivity and function the rodent striatum can be 
divided into dorsal and ventral portions. The dorsal striatum (or 
neostriatum) consists of the caudate-putamen, and is mainly 
sensorimotor related. It receives DA innervations primarily from the 
SNc and to a lesser degree from the VTA. The dorsal striatum 
receives glutamatergic inputs from sensorimotor related cortical 
areas [4]. The medium spiny GABAergic projection neurons in the 
dorsal striatum project to the substantia nigra reticulate (SNr) and 
the internal segment of the globus pallidus (GPi), forming the so-
called direct, monosynaptic pathway. Other striatal medium spiny 
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neurons project to the external segment of the globus pallidus (GPe) 
multisynaptically, via intermediate connections forming the indirect 
pathway. However, these two pathways are not strictly separated, as 
some MSNs project to the internal segment of the globus pallidus 
and also send axon collaterals to the external segment of the globus 
pallidus[5, 6]. The thalamus is another major input region of the 
neostriatum, with glutamatergic thalamostriatal neurons [2]. 
The ventral striatum which is composed of the NAc (nucleus 
accumbens) and portions of the olfactory tubercle is mainly limbic 
related. It receives DA innervations primarily from the VTA and to a 
lesser degree from the SNc. The NAc sends inhibitory projections to 
the VTA and surrounding DA areas, and receives its major 
glutamatergic input from the prefrontal cortex, the hippocampus, 
and the amygdale [4, 7, 8]. Figure 1 explains the connectivity to and 
from the striatum. 
The NAc affects cortical arousal, attention, and cognitive function 
through its projections to the basal forebrain cholinergic neurons 
[9]. The NAc participates in reward-based learning and addiction by 
serving as limbic-motor or motivation-action interface [4, 10]. 
A single dopamine neuron projecting to the striatum forms highly 
branched arbors, which constitutes 5.7% of the volume of the 
striatum, with a high density of axonal varicosities approximately 1 
million and form dopamine synapses at an incidence estimated at 1 
in every 10-20 µm3
 
 in the rat [11,12]. Although dopamine fibers 
make synaptic connections, DA receptors and DA uptake 
transporters exist extra synaptically [13-15]. Spillover of dopamine 
from the synapse into the extracellular space mediates extras 
ynaptic/volume transmission [16, 17, 18, 19], whereas ACh acts 
mainly via non-synaptic and diffuse transmission, released by the 
varicosities in addition to synaptic transmission [20]. 
Fig. 1: Correlation of various parts of brain within the striatum 
 
Cholinergic interneurons (ChIs) in the striatum 
The striatum is extremely rich in cholinergic interneurons [21]. The 
cholinergic interneurons in the striatum were identified as giant 
interneurons by kolliker, through his classic studies of a 
combination of golgi staining [22, 23] and intracellular labeling with 
immunochemistry for choline acetyl transferase [24]. In the striatum 
the cholinergic input arises solely from cholinergic striatal 
interneurons [1, 25, 26]. The ratio of medium sized neurons (mostly 
spiny projection neurons) to large cells (mostly cholinergic 
interneurons) is about 100 to 1 or 2 [27]. It is estimated that a total 
of 2.8 million neostriatum neurons are found on one side of a rat 
brain [28], and the number of cholinergic interneurons in a rat is 
approximately 40,000 per side. When compared to other cells in the 
neostriatum, the cholinergic interneurons are the one with large and 
extremely dense axonal arbors. The cholinergic arbors within the 
dorsal and ventral striatum are more reminiscent of dopaminergic 
arbours. As per quantitative electron microscopic studies there are 
approximately 2x108 ACh varicosities/mm3
Not only dopaminergic neurons, but also the cholinergic 
interneurons are critically involved in signaling unexpected primary 
rewards as well as signaling learning associated with events of high 
salience [26-37]. The cholinergic interneurons signal these events 
with a pause in firing, in a burst-pause-burst pattern [38, 39]. Like 
dopaminergic neurons striatal cholinergic interneurons form 
synapses primarily onto distal dendrites and dendritic spine necks 
in the striatum. In addition to the direct action at synaptic sites, ACh 
like DA may also influence striatal function via volume transmission 
[20, 40]. The highest expression of ACh, DA, tyrosine hydroxylase, 
choline acetyl transferase and acetylcholine esterase due to the 
extensive axonal arborization ensures that the cholinergic and 
dopaminergic system are positioned to interact within the striatum 
[31]. 
in the striatum and each 
striatal cholinergic interneuron has 500,000 axon varicosities. A 10 
µm radius sphere of striatal neutrophil contains about 400 
dopaminergic as well as cholinergic axon terminals [25, 29]. These 
cholinergic interneurons are spontaneously active in the striatum 
[30-32]. 
Dopamine receptors in the striatum 
Dopamine receptors are a class of metabotropic G protein coupled 
receptors. There are atleast 5 subtypes of dopamine receptors as 
identified by molecular cloning studies [41]. They are classified into 
D1 like family receptors (D1& D5) which are coupled to G protein GS 
that stimulates adenylyl cyclase and D2 like receptors (D2,D3,D4) 
which are coupled to Gi and inhibit adenylyl cyclase. The relative 
abundance of D1 like and D2 like receptors in the brain is in the 
order of D1>D2>D3>D5>D4 [41, 42, 43, 44]. The striatum has the 
highest expression of dopamine receptors in the brain. DA inputs to 
the striatum arise predominantly from the “A9-A10” dopamine 
neurons in the midbrain. The D1 and D2 receptors (and to a lesser 
extent D3,D4,D5,) on the striatal Spiny projection neurons can be 
classified into sub populations based on their expression levels [45, 
46, 47, 48, 49]. The activity of striatal spiny neurons can be altered 
by dopamine by modulating voltage dependent ion channels as well 
as excitatory and inhibitory synaptic inputs [49]. Based on some 
previous studies it is found that membrane excitability of striatal 
neurons is increased by the activation of D1 like receptors and 
decreased by the activation of D2 like receptors [18, 50, 51]. The 
state of the neurons also influences the effects caused by DA. The 
cholinergic interneurons in the striatum contain D2 receptors in 
both the short and long forms and to a lesser extent contain D5 
receptors mainly in the samotodendritic areas [46, 52]. These D5 
receptors may regulate the excitability and ACh release from 
cholinergic interneurons. Activation of D1 like (probably D5) can 
depolarize cholinergic interneurons and enhance ACh release 
[53,54,55,56,57], whereas activation of D2 like receptors inhibits 
striatal ACh efflux [55], through suppression of N type Ca2+
Muscarinic and nicotinic receptors in striatum 
 channels 
that directly initiate ACh release [52]. 
Autoradiography studies using tritriated agonist identified that 
cholinergic receptors expressed in the striatum are of both 
metabotropic muscarinic (mAChR) and ionotropic nicotinic (nAChR) 
families. Thus the striatum is richly endowed with both classes of 
cholinergic receptors. Nicotinic ACh receptors are composed of five 
subunits, which can be categorized into three classes based on their 
evolutionary relationship, their pharmacology and their physiology. 
These include muscle nAChRs and two classes of neuronal nAChR 
one class is formed from α-β subunit combinations (α2-α6,α10 and 
β2-β4), the other class from subunits which can form homo 
oligomeric neuronal nAChRs (α7-α9) and in the third class only the 
α7 subunit is widely distributed in the mammalian CNS [58]. Among 
the most commonly expressed nAChR subunits, the α4 and β2 
subunit is the first and is widely expressed throughout the 
mammalian brain including the midbrain DA areas and the striatum 
[59, 60] but the α7 containing nAChRs which are the next most 
common [61], are not highly expressed in the striatum. In the 
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mesostriatal DA system of the mouse, the β2 nAChRs are the most 
widely expressed, followed by α4 and α6 subunits. In the VTA and 
SN β2 nAChR are expressed on all DA neurons and most of the GABA 
neurons [62, 63, 64], whose activation increases excitability, action 
potential firing, and Ca2+ influx [62, 64, 65, 66]. DA axon terminals in 
the striatum express nAChR as indicated by histochemical and ion 
flux measurements with synaptosomes [60, 67, 68, 69]. 
Electrophysiological data, support the fact that striatal nAChRs are 
present only on the GABAergic interneurons, but not on the medium 
spiny neurons or cholinergic interneurons [58]. Molecular cloning 
has identified five different types of mAChRs, M1-M5 present on a 
variety of neurons and axon terminals throughout the striatum. 
They are divided into M1 like (M1,M3,M5) and M2 like (M2 and M4) 
in a similar manner as that of the DA receptors M1 like receptors are 
coupled to the Gs class of G2 proteins, whereas M2 like receptors are 
coupled to the Gi protein. M1, M2 and M4 are the dominant striatal 
muscarinic subtypes [70, 32]. MSNs express primarily M1 and M4, 
while M2, M3 and M5 subtypes are present in very low or 
undetectable levels [71, 72, 73, 74, 75, 76]. In contrast to MSNs, the 
striatal cholinergic interneurons have dominant expression of M2 
and M4
DOPAMINERGIC PATHWAYS IN CNS 
mAChRs [77, 78, 79, 80]. 
Nigrostriatal and mesocorticolimbic dopaminergic pathways are the 
two major dopaminergic (DA) systems in the CNS. The nigrostriatal 
DA system innervates the striatum and mediates excitatory and 
inhibitory influence, via dopamine D1 like (D1/D5) and D2 like 
(D2,D3,D4) receptors and acetylcholine (ACh) muscarinic M1 like 
(M1/M3/M5)and M2 like (M2/M4) receptors, of direct and indirect 
GABAergic striatal output pathways. Striatal neurons in the direct 
pathway utilize dopamine D1 receptors, whereas those in the 
indirect pathway utilize D2 receptors. D1 receptors activation 
stimulates adenylate cyclase there by activating the GABAergic 
substance P containing medium spiny output neurons, whereas D2 
receptors activation inhibits adenylate cyclase, there by inhibiting 
GABAergic enkephalin containing output neurons [81]. Thus the 
direct (via D1) and indirect (Via D2
The Mesocorticolimbic DA system consists of dopaminergic neurons 
originating in the VTA projecting via the medial forebrain bundle 
(MFB) to forebrain limbic and cortical areas [83]. Based on the 
localization of dopamine containing cell bodies within the VTA and 
their projection targets, it is further divided into two subsystems. 
The mesolimbic DA pathway is the one in which the dopaminergic 
cells of the paranigral VTA subdivision project to the NAc, amygdala, 
and hippocampus and (the central part of the reward system) the 
mesocortical DA pathway is the one in which the DA neurons of the 
parabrachial VTA subdivision project to the cortical structure [84]. 
However when compared to the other VTA projection target nuclei, 
the NAc is more established in the maintenance of goal directed 
behavior related to obtaining natural and artificial rewards as well 
as stimulus reward associations [85, 86]. 
) pathways have opposing 
actions, but the net outcome activating motor regions of the cortex is 
the same. In some, the striatal dopamine released from the 
nigrostriatal pathway finally facilitates voluntary movements 
through increasing thalamocortical activity either by direct or 
indirect reduction of GPi/SNr activity [82]. 
According to traditional views, nigrostriatal system with dopamine 
containing cell bodies in the substantia nigra pars compacta (SNC) of 
the midbrain and projecting to the dorsal striatum, play a role in the 
expression of motor acts, while the mesocorticolimbic system with 
dopamine containing cell bodies originating in the VTA of the 
midbrain and projecting largely to the nucleus accumbens and other 
ventral striatal regions such as hippocampus, amygdala and medial 
prefrontal cortex play a role in reinforcement/incentive 
motivational processes [83, 84, 87, 88]. However, it is not just 
mesocorticolimbic dopamine that is important for reward function; 
nigrostriatal dopamine is similarly important. 
The nigrostriatal and mesolimbic dopamine “systems” are not 
simply differentiated anatomically, and significant functional 
interactions between the two systems have been recently suggested 
[4, 89]. While it is the mesocorticolimbic dopamine system that is 
most frequently associated with brain stimulation reward, the 
dopaminergic fibers from the SN and the VTA each enter and project 
along the MFB [90], and reward sites are found in both SN and VTA 
[91]. 
Despite several kinds of heterogeneity both between SN and VTA 
dopamine neurons [92,93,94,95] and also within SN [96] and VTA 
[97,98,99] dopamine groupings, subsets of both SN and VTA 
dopamine neurons show the characteristic responses to reward and 
reward-predictive stimuli and to reward omission [100]. Indeed, the 
responses of SN and VTA neurons to rewards and reward-predictors 
are so indistinguishable that the electrophysiological data from cells 
in the two regions are traditionally pooled [100]. SN and VTA 
dopamine neurons share the same qualifying characteristics for 
whatever role dopamine neurons play in reward function. 
Afferents modulating the activity of dopaminergic neurons in 
the VTA 
Accumbal DA release is modulated by various afferents to the VTA 
such as the glutamatergic afferents from the lateral hypothalamus 
[101], bed nucleus of stria terminalis [102]and the superior 
coliculus [103], the GABAergic input, e. g. from the NAcc shell and 
medial part of ventral pallidum and the noradrenergic afferents 
from the locus coeruleus [104]. Activation of the GABAergic inter 
neurons in the VTA inhibits the release of accumbal dopamine [105]. 
5-HT afferents from the dorsal and medial raphe and the 
hypothalamic opioidic provide input via the ventral tegmental 
GABAergic interneurons [106, 107], thereby modulating the activity 
of the DA neurons in VTA. Moreover, the orexin containing 
projections from lateral hypothalamus to VTA also regulates the 
activity of ventral tegmental DA neurons [108,109,110]. Cholinergic 
neurons in additionally, the mesopontine areas i. e. the 
pedunculopontine tegmental area (PPTg) and laterodrosal 
tegmental area (LDTg) provide GABAergic input and thereby have 
an important modulatory role [108, 111, 112, 113]. 
Distinct action potential firing patterns of the dopaminergic 
neurons in the VTA 
Based on previous microelectrode studies two cell types are 
identified in the striatum which differ in the action potential firing 
patterns [114]. The cells which are often silent for seconds, but fire 
in brief episodes are commonly called phasically active neurons 
(PANS), which include medium spiny projection neurons of the 
striatum [115]. On the other hand cells which fire tonically at a rate 
that might vary, but which doesn’t exhibit long periods of silence are 
called tonically active neurons (TANS), cholinergic interneurons are 
of this type [116]. The mesostriatal DA neurons exhibit two broad 
and well defined firing modes in vivo; single spike firing in regular or 
irregular patterns (10Hz) and burst firing of 3-5 spikes at a 
frequency of 15-100Hz [117,118,119] and in between DA neurons 
are in a hyper polarized, quiescent state. A change from single to 
burst firing enhances and prolongs the signal strength, which in turn 
increases the DA levels in NAcc [120]. Initially presentation of a 
novel food reward [121], as well as conditioned stimulus associated 
with it leads to phasic burst firing of the DA neurons [122]. Later on 
as the reward becomes expected due to training the DA neurons 
loses their phasic bursting. 
CHOLINERGIC REGULATION OF THE VENTRAL TEGMENTAL AREA  
Cholinergic neurons are widely distributed throughout the brain [123, 
124] and have cognitive functions such as learning [125], memory 
[126] and attention [127]. Interestingly, cholinergic neurons have 
been identified in the mesopontine area i. e. the pedunculopontine 
tegmental area (PPTg) and (LDTg). Therese neurons project to various 
brain regions such as the thalamus, hypothalamus, basal forebrain, 
substantia nigra and medial limbic cortex. Additionally, the cholinergic 
neurons in the mesopontine area provide the only known cholinergic 
projections to the VTA [123]. Specifically, the cholinergic neurons of 
the LDTg projects to the VTA, whereas the PPTg mainly projects to 
substantia nigra [113-131]. The cholinergic neurons originating in the 
LDTg regulate the activity of ventral striatum while that of the PPTg 
regulates the activity of dorsal striatum [132-134]. However, it is 
unlikely that these relationships are wholly exclusive, as the VTA 
receives bilateral innervations not only from the LDT but also the PPN 
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(pedunculopontine tegmental nucleus) [130-137]. As seen with PPN, 
the LDT cholinergic neurons also project ipsilaterally to SNc 
dopaminergic neurons, but the projection is not as dense as that 
arising in the PPN [1,130,138]. Thus the PPN, rostral part of the 
brainstem cholinergic system projects ipsilaterally to the SNc, most 
caudal part of the midbrain dopaminergic system, whereas the medial 
and caudal parts of the brainstem cholinergic system (PPN caudal and 
LDT) project bilaterally to the VTA, the most rostral part of the 
midbrain dopaminergic system. The cholinergic projection from the 
LDTg to the VTA involves regulation of thedopaminergic, rather than 
the GABAergic mesoaccumbal neurons. And also it is important to note 
that the PPN cholinergic neurons are intermingled with non-
cholinergic neurons such as GABAergic and glutaminergic [139]. The 
cholinergic projection from the LDTg, together with the mesolimbic 
DA system constitutes the cholinergic dopaminergic reward link. This 
link is composed of the cholinergic projection from the LDTg to the 
VTA and the dopaminergic projection from the VTA and the 
dopaminergic projection from the VTA to the NAc. Activation of LDTg 
causes a release of ACh in the VTA which by interacting either with 
thenAChR and/or muscarinic mAChR stimulates the mesolimbic DA 
system causing a release of DA in NAc [140]. The cholinergic 
projections via mAchRs exert a tonic excitatory and the nAChRs exert 
phasic influence on the mesolimbic DA system respectively. The 
projections from the rostral part of the brain stem cholinergic system 
(PPN rostral) reach the most caudal part of the midbrain 
dopaminergic system (SNc). 
Mesopontine cholinergic modulation of the nigrostriatal 
dopaminergic system 
The mesopontine cholinergic system arises from neurons located in 
the LDT and PPT of the hindbrain [82]. Based on in vivo 
electrochemical studies activation of mAChRs located in the PPT 
inhibits striatal dopamine release by hyper polarization of 
mesopontine cholinergic cells [141,142] and a net decrease in 
excitation to SNc DA cells [134]. The M2
Activation of PPT cholinergic neurons could evoke striatal dopamine 
release through innervations of dopaminergic cells in the substantia 
nigra pars compacta directly by cholinergic and glutamatergic 
neurons in PPT and indirectly via glutamatergic neurons in the 
subthalamic nucleus (STN)[82]. In vivo fixed potential amperometry 
studies concluded that STN mAChRs, particularly of the M
 like mAChRs function as 
cholinergic autoreceptors as they are localized presynaptically on 
PPT cholinergic neurons and regulate the information received by 
the PPT [82]. Intra PPT infusions of scopolamine, a non-
selectivemAChR antagonist enhances striatal DA release as opposed 
to cholinergic agonist carbachol [143,144]. 
3
Mesopontine cholinergic modulation of the mesocorticolimbic 
da system 
 subtype, 
may be involved in the indirect activation of SNC DA cells via PPT-
STN-SNC pathways [145]. 
The cholinergic input from the LDT is required for burst firing of DA 
cells in the VTA [146],which conveys motivational information to NAC, 
which is involved in reward related processes [147]. LDT mAChRs, 
most likely M2
Electrical stimulation of the LDT as well as chemical stimulation of 
both mAChRs and nAChRs in the VTA excite mesolimbic DA neurons 
[149,150,151], and further facilitate dopamine release in the NAc 
[131,152,153]. The excitatory effect of ACh acting on VTA 
muscarinic and nicotinic AChRs influences incentive related 
behavior driven by DA activity. In rats, blockade of mAChRs in the 
VTA disrupts responding for food reward [154]. 
 auto receptor stimulation, hyperpolarizes LDT 
cholinergic neurons [141]. Nicotinic receptors containing α7,β2 and 
non α7 subunits mediate nicotinic actions on LDT cholinergic neurons 
[148]. 
INTERACTION OF THE CHOLINERGIC AND DOPAMINERGIC SYSTEM 
The dopaminergic and cholinergic systems are the primary and 
secondary largest neuromodulatory systems in the striatum [155]. 
Interactions between them are important and have been suggested 
to be mediated via correlated changes in neuron activities, 
reciprocal presynaptic regulation of neurotransmitter release, and 
through postsynaptic interactions [26, 35, 38, 58, 156]. Initial 
studies suggested that activation of the dopaminergic system 
generally inhibits the release of ACh. Indeed, later studies showed 
that D2 activation reduces whereas activation of the D1
In addition to the dopaminergic system modulating the cholinergic 
system, the cholinergic system also affects activity of the striatal 
dopaminergic system. However, the data are contradictory, and the 
mechanisms unresolved. Poor ligand selectivity has made it difficult 
to define the mAChR type(s) involved[157]. Some studies report that 
mAChRs enhance DA release [158-163],whereas some report 
suppression[160-165]. Recent data revealed that based on the 
activity of DA neurons, mAChRs regulate DA bidirectionally [166]. 
Activation of striatal mAChRs suppressed DA release by single 
pulses or low, tonic-like frequencies of presynaptic activity, but 
enhanced the sensitivity of DA release to frequency, thereby 
increasing DA released by higher frequencies [166]. Thus the 
sensitivity of DA release to frequency is enhanced either by 
activation of mAChRs or inhibition of nAChRs [167,168]. To 
investigate cholinergic influence over dopamine release, carbon-
fiber microelectrodes were placed into mice striatal brain slices, and 
fast cyclic voltammetry was used to monitor the concentration of 
action-potential-dependent dopamine release in real time. They 
found that cholinergic interneurons acting via nAChRs containing 
the β2 subunit potently regulate dopamine release.  
 receptor 
using specific agonists facilitates ACh release. 
However, unlike for striatal β2*-nAChRs, there is no anatomical 
evidence that striatal mAChRs are present on Dopaminergic axon 
terminals to influence DA release directly [32, 63, 164]. In contrast, 
many other striatal neurons express and are regulated by mAChRs, 
including striatal cholinergic interneurons [77, 78, 169, 170], 
GABAergic interneurons[40], GABAergic projection neurons [26-74], 
and glutamatergic afferents [26]. In contrast, the dynamic regulation 
of endogenous striatal DA release by mAChRs shown here requires 
ACh tone at β2*-nAChRs on DA axons: blockade of ACh input from 
cholinergic interneurons(ChIs) to β2
Dopaminergic neurons may possess M
-nAChRs precluded effects of 
mAChR agonists and vice versa. The somato dendritic and axonal 
mAChRs which are expressed on striatal cholinergic interneurons 
[78,169,171], are autoreceptors as seen with inhibition/ 
desensitization of nicotinic receptors. When these auto receptors are 
activated cholinergic interneurons become silenced and ACh release 
is inhibited [26,32,77,80,159,171,172,173], which further 
deactivates nAchRs on dopaminergic axons and in turn, increases 
the sensitivity of DA release to presynaptic depolarization 
frequency. These data offer support generally for thehypothesis that 
the outcome of changes in DA neuron activity will depend critically 
on any accompanying changes in ChIs [38].  
5-mAChRs in midbrain for 
modulation by mesopontine afferents [71,174,175], but there is 
currently no anatomical evidence that mAChRs are located on 
Dopaminergic axons. Striatal ChIs in contrast, which release ACh and 
regulate DA release via β2-subunit-containing nicotinic AChRs (β2*-
nAChRs) on dopaminergic axons, express M2- and/or M4-mAChRs 
[77, 78, 79, 80, 173]. These M2/M4-mAChRs regulate cholinergic 
interneuron’s activity and Ach [77,159,160] and might therefore 
gate β2*-nAChR function by controlling ACh availability. Since β2
mAChR antagonist’shimbacine and tropicamide, at concentrations 
selective for M
*-
nAChRs either inhibits or facilitates DA release depending on the 
frequency of presynaptic activity in DA axons [156,176,177], 
mAChRs on ChIs might also regulate DA release probability in a 
bidirectional manner. 
2/M4-mAChRs, competed with the effects of mAChR 
agonists, implicating M2/M4-type mAChRs throughout striatum. 
This finding is consistent with the expression of M2/M4-mAChRs by 
ChIs [77, 78, 79, 80, 173]. However, several pieces of data suggested 
differing M2/M4 function between striatal territories. Furthermore, 
whereas knock-out of theM4R prevented mAChR effects throughout 
striatum, knock-out of M2Rs prevented mAChR control of DA release 
only incaudate-putamen (CPu). These data suggest thatM4Rs are 
necessary for mAChR regulation of DA (and ACh) release throughout 
the striatum but that M2Rs are necessary only in CPu, where 
bothM4Rs andM2Rs are required [166].  
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Thus, distinct muscarinic mechanisms/receptors in subpopulations 
of ChIs may explain the differing mAChR control of DA release in CPu 
and NAc. These regional differences in M2/M4 function could 
ultimately be exploited for discrete modulation of DA/ACh. For 
example, ACh/DA function might be modified selectively in NAc by 
activation of M4Rs, and in CPu by M2R inhibition [166]. DA release 
probability within the striatum is relatively high following a single 
action potential, whereas subsequent action potentials within a 
burst of action potentials are limited by short term depression 
[178,179]. However, ACh and presynaptic nAChRs control the DA 
release probability based on the activity of DA neurons and the 
multiple nAChR subunits [31,166,176,177,180,181]. Administration 
of nAChR antagonist or desensitization of nAChRs using nicotine 
reduces ACh action at nAChRs thereby reducing initial DA release 
probability and subsequently relieves short term depression 
[176,177]. Activation of nAChRs by ACh regulates DA axons release 
in response to single or low frequency action potentials as well as 
high frequency action potential, e. g. in a burst. Thus, nAChRs limits 
striatal DA release in response to frequency of activity of DA 
neurons in midbrain by acting as a low frequency pass filter and 
when they are turned off they act as a “high frequency pass” filter as 
the striatal DA release becomes highly sensitive to the frequency of 
activity of a neuron [156,176]. Thus reduced nAChR activity can 
either increase DA release during bursts of DA neuron activity 
(>20Hz) such as that seen after presentation of an unexpected 
reward or conditioned salient stimuli [119,182] and reduce DA 
release during low DA neuron activity such as that seen after 
omission of an expected reward [183]. By acting at the source of DA 
(in the midbrain) and at the target of DA fibers (in the striatum), 
nicotinic mechanisms exert multiple regulatory influences over DA 
signalling. Via those normal nicotinic mechanisms, the addictive 
drug, nicotine, exerts modulatory influences over the mesostriatal, 
mesocortical, and mesolimbic DA systems. Previous studies using 
the α6 selective nAChR antagonist α-CTXMII has revealed that α6 is 
the dominant nAChR subunit responsible for DA transmission in 
ventral striatum [180], whereasα6 , α4, β2 nAChRs may dominate 
β2
CONCLUSION  
nAChR function in NAc [184]. 
The cholinergic neurons in the pons region of the Hind brain, the 
PPT and LDT, provide the only known cholinergic projections to the 
SNc and VTA respectively. The activation of mesopontine cholinergic 
projection innervating the VTA causes a release of ACh which by 
interacting with nAChR/mAChR produces excitation of dopamine 
neurons and facilitates dopamine release in the NAcc. Thus 
dopamine’s incentive-related behaviors are influenced by the 
excitatory effect of ACh in the VTA. 
Furthermore, the mAChRs are known to regulate dopamine 
bidirectionally depending upon the activity of DA neurons. They do 
not simply suppress or enhance DA release but can do both 
depending on the frequency of depolarization and this variable 
mAChR control of DA release is not via variable striatal neuron types 
but is via the control of ACh release from striatal ChIs. While the 
cholinergic projections of mAChRs exert a tonic excitatory influence, 
nAChRs exert a phasic influence on the mesolimbic DA system. 
As many neuropsychiatric disorders are manifestation of 
fluctuations in ACh and DA levels, their interaction should be given 
appropriate consideration. 
Previous studies indicated that dopamine is necessary to elicit 
neural activity in the accumbens that drives the behavioral 
responses to cues. However the actual contribution of ACh towards 
this behavioral response is not known. It will be of great value to 
determine whether ACh apart from dopamine is also a powerful 
modulator of goal-directed behavioral responses. 
Further research detailing the nature of the interactions between 
dopamine and ACh is necessary to precisely define their 
contributions towards these goal-directed behavioral responses. 
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